Latest Breaking News On - Edgewise therapeutics - Page 1 : comparemela.com

Frazier Life Sciences Management L P Boosts Stock Holdings in Edgewise Therapeutics, Inc (NASDAQ:EWTX)

Frazier Life Sciences Management L.P. lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 214.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,667,203 shares of the company’s stock after buying an additional 1,818,181 shares during the […]

New yorkUnited statesBehrad derakhshanPiper sandlerR michael carruthersEdgewise therapeutics company profileExchange commissionFrazier life sciences managementYork state common retirement fundSg americas securitiesSchonfeld strategic advisorsEdgewise therapeutics incRoyal bankCorton capital incEdgewise therapeuticsFree report

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake immunotherapeuticsArcutis biotherapeuticsZealand pharmaVerona pharmaBridgebio pharmaMohit bansalNeurocrine biosciencesIovance biotherapeuticsWells fargoAlnylam pharmaceuticalsRhythm pharmaceuticalsApellis pharmaceuticalsArrowhead pharmaceuticalsAmicus therapeuticsXenon pharmaceuticalsMadrigal pharmaceuticals

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol s Camzyos

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol s Camzyos
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol myers squibbBristol myer camzyosSerge belangerRoanna ruizBristol myersJoseph schwartzRobert blumNeedham belangerEuropean medicines agencyDrug administrationLexicon pharmaceuticalsRisk evaluationMitigation strategyRivaling bristolChief executive robert blumBristol myer

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol s Camzyos

Bristol myer camzyosBristol myers squibbBristol myersJoseph schwartzRobert blumRoanna ruizEuropean medicines agencyLexicon pharmaceuticalsDrug administrationChief executive robert blumRivaling bristolKansas city cardiomyopathyRisk evaluationMitigation strategyEdgewise therapeuticsTenaya therapeutics

HHS panel to vote in Nov on DMD screening for newborns (NASDAQ:SRPT)

HHS panel to vote in Nov on DMD screening for newborns (NASDAQ:SRPT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Screening panelUs department of healthAdvisory committee on heritable disorders in newbornsWave life sciencesVertex pharmaceuticalsHuman servicesMuscular dystrophy associationAdvisory committeeHeritable disordersUniform screening panelEndpoints newsParent project muscular dystrophyEdgewise therapeuticsDyne therapeuticsSolid biosciences